ASCEND BY NTHRYS
Research Abroad Products

Molecular Pathology Project Topics

Browse all focused areas across all project categories under this field.

Showing 25–36 of 200 project topics
Pharmacogenomics Testing Platform and Clinical Decision Support
Integrated SaaS platforms that perform genetic testing for drug metabolism genes, predict medication efficacy and adverse reactions, and deliver real-time clinical decision support to prescribers and patients. Healthcare systems and pharmacies use this to reduce adverse drug events, improve medication adherence, and establish recurring testing services that scale across multiple patient populations.
Molecular Pathology Companion Diagnostic Dev Click to view more details →
Viral and Microbial Pathogen Identification Diagnostic Platform
Molecular diagnostic tools and cloud software that rapidly identify and characterize viral, bacterial, and fungal pathogens from clinical specimens using multiplexed PCR, sequencing, or MALDI-TOF technologies. Clinical laboratories monetize this through high-volume infectious disease testing, hospital contracts, and value-added reporting that drives faster pathogen identification and appropriate antimicrobial therapy selection.
Molecular Pathology Companion Diagnostic Dev Click to view more details →
Hereditary Cancer Risk Genomic Testing and Risk Stratification
End-to-end SaaS platforms and laboratory services that screen for pathogenic germline variants in cancer susceptibility genes (BRCA1/2, Lynch syndrome genes, etc.) and provide personalized risk assessment and clinical recommendations. This creates recurring revenue through direct testing services, insurance reimbursement, and preventive medicine programs that identify high-risk individuals for enhanced surveillance and early intervention.
Molecular Pathology Companion Diagnostic Dev Click to view more details →
Minimal Residual Disease and Tumor Burden Monitoring Software
Precision oncology software platforms that detect and quantify circulating tumor DNA and minimal residual disease using ultra-sensitive molecular assays to monitor cancer recurrence and treatment response. Pharmaceutical companies and oncology centers deploy this to support clinical trials, enable personalized treatment adjustments, and establish high-value monitoring services for cancer patients in remission.
Molecular Pathology Companion Diagnostic Dev Click to view more details →
Immunotherapy Biomarker Testing and Predictive Analytics Platform
Commercial diagnostic platforms that measure tumor mutational burden, microsatellite instability, PD-L1 expression, immune cell infiltration, and other predictive biomarkers to identify immunotherapy-responsive patients and guide checkpoint inhibitor selection. Oncology practices and pharmaceutical sponsors leverage this to improve patient selection in clinical trials, predict treatment response, and establish companion diagnostics that increase drug efficacy and revenue.
Molecular Pathology Companion Diagnostic Dev Click to view more details →
Laboratory Information Management System for Molecular Testing
Specialized LIMS and workflow automation software designed for molecular pathology laboratories to manage specimen tracking, assay execution, result reporting, and quality assurance across multiple molecular test types and platforms. Clinical laboratories, reference labs, and hospital systems deploy this to reduce manual errors by 50-70%, accelerate test turnaround, and support compliance with CLIA/CAP regulations while enabling scalable high-throughput testing operations and data integration with EHR systems.
Molecular Pathology Companion Diagnostic Dev Click to view more details →
Clinical NGS Panel Design and Customization Platform
A SaaS platform enabling laboratories to design, validate, and deploy custom NGS gene panels tailored to specific clinical indications and patient populations. This service generates recurring revenue through subscription licensing, panel update fees, and consultation services for assay optimization.
Molecular Pathology NGS Service Platforms Click to view more details →
Automated Variant Interpretation and Classification Engine
A cloud-based AI tool that automatically classifies genetic variants using clinical databases, predictive algorithms, and evidence-based guidelines to streamline pathologist workflows. The platform monetizes through per-variant analysis fees, institutional subscriptions, and premium tiered access to advanced interpretation modules.
Molecular Pathology NGS Service Platforms Click to view more details →
Real-time NGS Data Quality Control and Analytics Dashboard
An enterprise software solution providing real-time monitoring of sequencing run quality metrics, coverage analysis, and performance benchmarking across multiple NGS instruments. Revenue streams include per-run processing fees, analytics subscriptions, and data integration partnerships with instrument manufacturers.
Molecular Pathology NGS Service Platforms Click to view more details →
Multi-gene Cancer Mutation Profiling and Reporting Service
A comprehensive commercial NGS service offering targeted sequencing of cancer-relevant genes with automated report generation, treatment recommendations, and clinical trial matching. The service generates revenue through per-sample testing fees, institutional volume contracts, and pharmaceutical partnership programs.
Molecular Pathology NGS Service Platforms Click to view more details →
Infectious Disease Pathogen Detection NGS Platform
A specialized NGS service platform designed for rapid identification and antimicrobial resistance profiling of bacterial, viral, and fungal pathogens from clinical specimens. This platform creates revenue through per-test billing, urgent turnaround time premiums, and hospital laboratory service contracts.
Molecular Pathology NGS Service Platforms Click to view more details →
Germline Hereditary Disease Risk Assessment Software Suite
A comprehensive SaaS platform for interpreting germline variants associated with hereditary cancers, cardiac conditions, and metabolic disorders with integrated family history analysis. Revenue is generated through per-patient analysis subscriptions, genetic counselor licensing, and direct-to-consumer clinical report sales.
Molecular Pathology NGS Service Platforms Click to view more details →